STK11

Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratoma.

Nakagawa A, Tamauchi S, Xinyuan W

Lung Carcinoma Metastatic to Breast: A Comprehensive Analysis of Clinical Presentation, Morphologic and Molecular Features, with Emphasis on Diagnostic Pitfalls.

Hashmi AA, Vougiouklakis T, Gazzo A

Case Report: From teratoma to adenocarcinoma: molecular insights into somatic-type malignancy in testicular germ cell tumors - two case reports and review of the literature.

Rozsvai T, Pósfai B, Torday L

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study.

Skoulidis F, Borghaei H, Garon EB

Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing.

Hertel A, Streuer A, Diehl S